-
Have you not? Investor Presentation page 33
-
-
-
Member
Normally share price plummets after I buy, but this one has gone up quite a bit! FDA approval is no small feat and the reason why I decided to buy. Total revenue was only 240K last year and this year my forecast is 1.5 million. 5.1 million cash in hand as of March 2019.
Market cap now is 112 million as I type!
Decision time - buy more or sit tight?
-
Running too fast ,flying too high! Re 85.5c atm!. Luckily i got set early so in my situ im holding on for the ride .Im not thinking of adding,free carrying or taking some profits YET ,because there is such strong momentum here.
Need more sign ups.I do wonder if a big player is building a position.
Ive seen a spread sheet with a guestimate of over $4 mill rev 2019 increasing to $12 mill plus in 2020 based on US$700 per unit (retail $1500), 4 sleep centres signed up per month with min 20 orders each p/m etc.
Last edited by Joshuatree; 25-09-2019 at 06:33 PM.
Reason: guesstimate
-
Great overview here well worth a listen. Former head of Macquarrie on board and 3 million failed CPAP users in the USA alone looking for another solution just two points.
The Health Kick Podcast with Tim Boreham: Oventus Medical
-
-
-
Share price based on future sales, getting pretty frothy. I may sell a few sometime on the road to free carried. Good to see Cyan Fund onboard .
http://www.cyanim.com.au/2019/10/08/cyan-newsletter-30-september-2019/
-
First lab in lab sites operational in Canada and US
Like that phrase in there.Its not well positioned but "Strongly Positioned"
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks